Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8186
Reference
Drug Alert 22/2024
Name
Drug Alert Class 4 Drug Alert 22 2024 – Class 4 medicines defect information caution in use – Viatris Healthcare UK Ltd- Oxcarbazepine Mylan 150MG, 300MG, 600MG film-coated tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Viatris UK Healthcare Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in the above specified batches of Oxcarbazepine 150 mg, 300 mg & 600 mg Film-Coated Tablets do not contain the most up to date safety information.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-06-18 11:40:00
Click to go back to homepage